Kazuhiko Ide

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

Lymphoid Neoplasia, End-of-induction Pet Response, Medicine +7

Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-Transplanted NOD/SCID Janus Kinase 3 Knockout Mice

Shin-ichiro Hattori, Kazuhiko Ide, Hirotomo Nakata et al. · Antimicrobial Agents and Chemotherapy · 2009 · 52 citations · Full text

Immunology, Antiviral Drug, Immunotherapy +17

Novel HIV-1 Protease Inhibitors (PIs) Containing a Bicyclic P2 Functional Moiety, Tetrahydropyrano-Tetrahydrofuran, That Are Potent against Multi-PI-Resistant HIV-1 Variants

Kazuhiko Ide, Manabu Aoki, Masayuki Amano et al. · Antimicrobial Agents and Chemotherapy · 2011 · 26 citations · Full text

Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1

Manabu Aoki, Matthew Danish, Hiromi Aoki-Ogata et al. · Journal of Virology · 2012 · 24 citations · Full text

Design and Synthesis of Stereochemically Defined Novel Spirocyclic P2-Ligands for HIV-1 Protease Inhibitors

Arun K. Ghosh, Bruno D. Chapsal, Abigail Baldridge et al. · Organic Letters · 2008 · 16 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Bioorganic Chemistry +13